GIMBHI’s daily mental health update — 11/12/26

🎓 MYRIAD trial 2-year follow-up: school-based mindfulness training offers little pupil benefit, but teacher gains persist (Jones, Ball et al., BMJ Mental Health) — 11/02/26
TL;DR: UK cluster RCT of 85 schools and 8,376 pupils found universal school-based mindfulness training was not superior to usual social-emotional teaching for adolescent mental health at 2 years, but improved teacher well-being, stress, and school climate.

💊 ASCP Delphi panel finds limited consensus on ketamine/esketamine use for mood disorders (Sanacora, Goldberg et al., J Clin Psychiatry) — 11/02/26
TL;DR: 21-expert international panel reached consensus on only 35 of 105 items regarding ketamine/esketamine practice, highlighting gaps between real-world use and evidence base for dosing, formulations, and non-depression indications.

🎖️ Meta-analysis: psychosocial interventions cut suicide attempts in US veterans but not suicidal ideation (Ciesinski, Trikeriotis et al., Journal of Affective Disorders) — 02/01/27
TL;DR: Review of 41 controlled trials (N=5.5M) found suicide prevention interventions reduced suicide attempts (RR=0.68) and self-harm (RR=0.79) among US military and veterans, but not suicidal ideation.

🎖️ VHA users had 20% lower suicide rate than non-users after Army separation (Brenner, Forster et al., JAMA Network Open) — 11/05/26
TL;DR: Cohort of 649,811 Army veterans found VHA users had age-adjusted suicide rate of 28.77 vs 35.92 per 100,000 person-years for non-users, with lower hazard rates in first two years post-separation.

Next
Next

GIMBHI’s daily mental health update — 11/11/26